Bludigo
Active substance: indigotindisulfonate
INJECTION · INDIGOTINDISULFONATE SODIUM 8 mg/mL
United StatesActive
Marketing holder: Sagent Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- INDIGOTINDISULFONATE SODIUM · 8 mg/mL
Registration
- Registration number
- 25021-840
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 25021-840 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 25021-840 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 25021-840 · Verified 2026-10-09 · open in source